Patents Examined by Jody Karol
  • Treatment of neural diseases or conditions
    Patent number: 8642658
    Abstract: Compounds, methods, uses, compositions, kits and packages for the prevention and/or treatment of neural injury or a neurodegenerative disease, based on the use of a retinoic acid derivative, such as fenretinide, and/or analogs, derivatives, pro-drugs, precursors thereof, and/or salts thereof, are described.
    Type: Grant
    Filed: February 20, 2009
    Date of Patent: February 4, 2014
    Assignee: Royal Institution for the Advancement of Learning/McGill University
    Inventors: Danuta Radzioch, Samuel David, Ruben Lopez-Vales, Thomas Skinner
  • N-acetyl-L-cysteine for the treatment of endometriosis
    Patent number: 8637573
    Abstract: The invention relates to a new prescription of NAC in the treatment of endometriosis and of indications associated with endometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of endometriosis is proposed. In one embodiment of the present invention the prescribed treatment regimen may be used e.g. in order to control the frequency and the intensity of pain symptoms (dysmenorrhea, dyspareunia and acyclic chronic pelvic pain), to reduce the size of endometriotic lesions eventually up to their disappearance, to reduce recurrences after surgery and/or to improve fertility. Side effects of this treatment are virtually absent and, in particular, this treatment does not hinder pregnancy.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: January 28, 2014
    Assignee: Iasomai AB
    Inventors: Tiziana Parasassi, Maria Grazia Porpora
  • Omega-3 fatty acids for osteoarthritis
    Patent number: 8633246
    Abstract: Methods for restoring a more nearly normal joint function in an osteoarthritic dog and methods for decreasing the likelihood of a dog developing osteoarthritis involve administering to the dogs a composition containing an effective concentration of the omega-3 fatty acid, eicosapentaenoic acid (EPA).
    Type: Grant
    Filed: August 6, 2004
    Date of Patent: January 21, 2014
    Assignee: Hill's Pet Nutrition, Inc.
    Inventors: Dale A Fritsch, Dennis E Jewell, William D Schoenherr
  • Method for decreasing cartilage damage in dogs
    Patent number: 8633247
    Abstract: A method for modulating enzymatic degradation of articular cartilage in a dog comprises administering to the dog an enzymatic degradation modulating effective amount of eicosapentaenoic acid (EPA), for example as a component of a food composition. By practice of the method in a dog having arthritis, mobility of the dog can be increased, weight bearing in an arthritic limb can be increased, and/or pain associated with arthritis can be reduced.
    Type: Grant
    Filed: February 14, 2005
    Date of Patent: January 21, 2014
    Assignee: Hill's Pet Nutrition, Inc.
    Inventors: Bruce Caterson, Christopher Bond Little, John Leander Harwood, John Francis Innes, Dale A. Fritsch, Dennis Edward Jewell, William David Schoenherr
  • Methods for decreasing cartilage damage in dogs
    Patent number: 8629183
    Abstract: A method for modulating enzymatic degradation of articular cartilage in a dog comprises administering to the dog an enzymatic degradation modulating effective amount of eicosapentaenoic acid (EPA), for example as a component of a food composition. By practice of the method in a dog having arthritis, mobility of the dog can be increased, weight bearing in an arthritic limb can be increased, and/or pain associated with arthritis can be reduced.
    Type: Grant
    Filed: June 22, 2010
    Date of Patent: January 14, 2014
    Assignee: Hill's Pet Nutrition, Inc.
    Inventors: Bruce Caterson, Christopher Bond Little, John L. Harwood, John Francis Innes, Dale A. Fritsch, Dennis Edward Jewell, William David Schoenherr
  • Method for decreasing cartilage damage in dogs
    Patent number: 8629182
    Abstract: A method for modulating enzymatic degradation of articular cartilage in a dog comprises administering to the dog an enzymatic degradation modulating effective amount of eicosapentaenoic acid (EPA), for example as a component of a food composition. By practice of the method in a dog having arthritis, mobility of the dog can be increased, weight bearing in an arthritic limb can be increased, and/or pain associated with arthritis can be reduced.
    Type: Grant
    Filed: June 22, 2010
    Date of Patent: January 14, 2014
    Assignee: Hill's Pet Nutrition, Inc.
    Inventors: Bruce Caterson, Christopher Bond Little, John L. Harwood, John Francis Innes, Dale A. Fritsch, Dennis Edward Jewell, William David Schoenherr
  • Synergistic combinations of VR-1 antagonists and COX-2 inhibitors
    Patent number: 8618120
    Abstract: A synergistic combination of a vanilloid receptor VR-1 antagonist and an NSAID or a pharmaceutically acceptable salt or solvate of either or both compounds thereof.
    Type: Grant
    Filed: July 16, 2008
    Date of Patent: December 31, 2013
    Assignee: Novartis AG
    Inventors: Alyson Fox, Mark Nash, Bindi Sohal, Elliot Lilley
  • Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
    Patent number: 8609722
    Abstract: Compositions having a mixture of lidocaine, prilocaine and tetracaine, or their pharmaceutically acceptable salts. A preferred composition includes the following components in the indicated approximate w/w percentages: 1.5% lidocaine base; 1.5% prilocaine base; 4% tetracaine base and water. In some implementations, also included may be about 10% methylpynrolidone; 2% dimethyl sulfoxide; 0.08% topical hyaluronidase; 1.5% guar gum; 1% polyoxyethylenesorbitan monolaurate; 0.5 polyoxyethylenesorbitan monooleate, and water to 100%. Such compositions exhibits a high concentration on skin, a deep anesthetic effect and a significantly more rapid onset of the anesthetic effect than comparable transdermal anesthetics.
    Type: Grant
    Filed: June 1, 2004
    Date of Patent: December 17, 2013
    Inventor: Fernando Bouffard Fita
  • Solid cosmetic composition
    Patent number: 8604079
    Abstract: The present invention relates to a solid cosmetic composition comprising, as a structure agent, a combination consisting of a saturated straight-chain polymer and an agglutinating agent for this polymer. The composition of the invention has a rigid, moldable and stable structure, being suitable for application as, for example, lipstick, blush, eye shadow, stick base, lip protectors (either colorful or colorless), deodorants, perfumes, among others.
    Type: Grant
    Filed: February 28, 2008
    Date of Patent: December 10, 2013
    Assignee: Nature Cosmeticos S.A.
    Inventors: Adriana Amaral Rodrigues, Claudia Léo
  • Acridone compounds
    Patent number: 8592447
    Abstract: A class of acridone compounds has been discovered that exhibits chemosensitizing and antiparasitic activity. Described herein are pharmaceutical compositions and methods for their use to treat parasitic infections, such as malaria and toxoplasmosis, and to sensitize resistant cells, such as multidrug resistant cells to other therapeutic agents. The pharmaceutical compositions and methods may also be used to treat and/or prevent psychotic diseases such as schizophrenia.
    Type: Grant
    Filed: November 13, 2007
    Date of Patent: November 26, 2013
    Assignees: Oregon Health & Science University, The United States of America, as represented by the Department of Veterans Affairs
    Inventors: Michael K. Riscoe, Rolf Winter, Jane X. Kelly, David J. Hinrichs, Martin J. Smilkstein
  • Non-mucoadhesive film dosage forms
    Patent number: 8580830
    Abstract: Orally disintegrating film dosage forms for delivering active pharmaceutical agents, methods of formulating the dosage forms to retard absorption through the oral mucosa, and methods of using the dosage forms for the treatment of various medical conditions are provided.
    Type: Grant
    Filed: October 2, 2007
    Date of Patent: November 12, 2013
    Assignees: Labtec GmbH, APR Applied Pharma Research S.A.
    Inventors: Christian Leichs, Armin Breitenbach, Ingo Lehrke, Paolo Galfetti
  • Dosage form for hormonal contraception
    Patent number: 8580771
    Abstract: A dosage form for hormonal contraception containing a given number of hormone-containing daily units and a given number of hormone-free daily units for daily, oral administration, where the hormone-containing daily units each contain at most the minimum effective daily amount of folic acid for women and the hormone-free daily units contain at least a multiple of this amount up to the maximum permissible amount of folic acid for women.
    Type: Grant
    Filed: October 6, 2005
    Date of Patent: November 12, 2013
    Assignee: Richter Gedeon Nyrt.
    Inventors: Georg Schramm, Eric-Paul Paques
  • Method of preventing or ameliorating psoriasis using pyrroloquinoline quinone compounds
    Patent number: 8575190
    Abstract: The present invention provides a method for preventing or ameliorating skin psoriasis by applying as an active ingredient, a compound represented by general formula (I) or a salt thereof: (wherein R1, R2, and R3 simultaneously or separately represent a lower alkyl, lower alkenyl, lower alkynyl, aralkyl, araryl, or phenyl group, or a hydrogen atom).
    Type: Grant
    Filed: November 12, 2008
    Date of Patent: November 5, 2013
    Assignee: Mitsubishi Gas Chemical Company, Inc.
    Inventors: Ayako Kamimura, Toshikazu Kamiya, Masahiko Nakano, Kazutoshi Kikkawa
  • Compositions comprising tramadol and celecoxib in the treatment of pain
    Patent number: 8569271
    Abstract: The present invention relates to pharmaceutical compositions comprising tramadol and celecoxib and their uses as medicaments or analgesics, more particularly for the treatment of severe to moderate pain with an inflammation component.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: October 29, 2013
    Assignee: Laboratorios del Dr. Esteve, S.A.
    Inventors: Enrique Portillo Salido, Sebastia Videla Ces
  • Dermatological compositions comprising retinoids, dispersed benzoyl peroxide and carrageenans
    Patent number: 8557871
    Abstract: Dermatological compositions containing, in a physiologically acceptable medium, at least one retinoid, dispersed benzoyl peroxide and at least one gelling agent of the family of the carrageenans, are useful for treating dermatological conditions and afflictions linked to disorders of cell differentiation and/or proliferation and/or keratinization, notably for treating acne vulgaris.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: October 15, 2013
    Assignee: Galderma Research & Development
    Inventors: Fabienne Louis, Sandrine Segura, Nathalie Willcox
  • Methods of treatment utilizing topical emulsion-gel composition comprising diclofenac sodium
    Patent number: 8557870
    Abstract: The invention relates to methods for treating burns or inflammation utilizing beneficial pharmaceutical compositions comprising diclofenac sodium salt in unusually low amounts. The compositions represent opaque emulsion-gels, in which diclofenac is kept fully dissolved.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: October 15, 2013
    Assignee: Novartis Consumer Health S.A.
    Inventor: Michel Steiger
  • 7-substituted indirubin-3?oximes and their applications
    Patent number: 8552053
    Abstract: The invention relates to new 3?-, 7-substituted-indirubins of formula (I) wherein R represents N—OH, N—O-alkyl or N—O—CO-alkyl, NO—(Ra)n1-Het, N—O—(Y)n1—N Ra Rb, N—O—CO—N(Rb Rc), radical with Het representing an aliphatic nitrogeneous heterocycle, Y being an optionally substituted —CH2— radical, n1 being 1 to 3, and X is an halogen atom selected in the group comprising F, Cl, Br, I, and Z is H or CH3 and the salts thereof.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: October 8, 2013
    Assignees: Centre National de la Recherche Scientifique, University of Pierre and Marie Curie (Paris 6), University of Rennes 1, University of Lleida, Universite d'Athenes
    Inventors: Laurent Meijer, Karima Bettayeb, Alexios-Le-Andros Skaltsounis, Prokopios Maglatis, Jacint Boix, Judit Ribas
  • Solvent-based sterilisation of pharmaceuticals
    Patent number: 8541399
    Abstract: A sterile composition of a pharmaceutical compound is prepared by combining solvent with a non-sterile pharmaceutical compound to form a solution and filtering to yield a sterile pharmaceutical compound, optionally removing all or part of the solvent, and under sterile conditions combining the compound with a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: February 19, 2003
    Date of Patent: September 24, 2013
    Assignee: Resolution Chemicals Limited
    Inventors: Parveen Bhatarah, Kenneth Alan Greenwood
  • Resin powder for dermatologic composition, skin cleansing agent and cosmetic composition using the powder, and preparation processes of the powder
    Patent number: 8518424
    Abstract: Provided is a resin powder for a dermatologic composition composed of resin particles having an average volume particle size of 2.0 to 20.0 ?m, a shape factor SF1 of 110 to 140 and an average volume particle size distribution GSDv of 1.3 or less. Also disclosed are a skin cleansing composition and a cosmetic composition containing the resin powder, and a preparation process of the resin powder.
    Type: Grant
    Filed: September 5, 2007
    Date of Patent: August 27, 2013
    Assignee: Fuji Xerox Co., Ltd.
    Inventors: Yuki Sasaki, Yasuo Matsumura, Takayoshi Aoki, Etsuo Tominaga
  • Combination of anticholinergics, ?2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases
    Patent number: 8518918
    Abstract: The invention relates to novel combinations based on anticholinergics, ?2-adrenoceptor agonists, PDE 4 Inhibitors, glucocorticoids, and leukotriene-receptor antagonists, process for their production and their use for the treatment of inflammatory diseases, preferably respiratory diseases as bronchial asthma and chronic obstructive pulmonary diseases (COPD) or rheumatic or autoimmune diseases.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: August 27, 2013
    Inventors: Joachim Maus, Kastrup Horst, Istvan Szelenyi, Peter Jurgen Cnota, Bauhofer Artur